Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and Recovery
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
An Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Participants
- Status
- TERMINATED
- Phase
- N/A
ABC294640 (Opaganib) in Refractory / Relapsed Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Phase I/II Study of BI-505 in Conjunction With Autologous Stem Cell Transplant in Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Panobinostat in Combination With Carfilzomib and Dexamethasone in Relapsed or Relapsed and Refractory Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE2
Daratumumab in Combination With ATRA
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Revlimid® Capsules Special Drug Use-results Survey (in Patients With Newly-diagnosed Multiple Myeloma [NDMM])
- Status
- COMPLETED
- Phase
- N/A
Comparison of Ibandronate - Zoledronate Regarding Nephrotoxicity in Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE3
To Compare Conservative Management Vs. Balloon Kyphoplasty in the Treatment of VCFs in Patients With Multiple Myeloma
- Status
- TERMINATED
- Phase
- NA
Dendritic Cell/Myeloma Fusion Vaccine for Multiple Myeloma (BMT CTN 1401)
- Status
- COMPLETED
- Phase
- PHASE2
An Investigational Immuno-therapy Study of Nivolumab, Pomalidomide and Dexamethasone Combinations in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Panobinostat (LBH589): Multiple Myeloma - Autologous Hematopoietic Cell Transplantation (HCT)
- Status
- COMPLETED
- Phase
- PHASE2
UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep
- Status
- COMPLETED
- Phase
- PHASE2
A Trial Evaluating Efficacy & Safety of RVD +/- Panobinostat in Transplant Eligible, Newly Diagnosed Multiple Myeloma (NDMM)
- Status
- TERMINATED
- Phase
- PHASE2
Refining a Biobehavioral Intervention to Enhance Recovery Following Hematopoietic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- NA
Continuing Treatment for Participants Who Have Participated in a Prior Protocol Investigating Elotuzumab
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Elotuzumab With Pomalidomide, Bortezomib, and Dexamethasone in Relapsed Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase 1 Study of Tremelimumab, Durvalumab, High-dose Chemotherapy, + Autologous Stem Cell Transplant
- Status
- TERMINATED
- Phase
- PHASE1
Exploratory Trial to Estimate Proportion of Patients With Tumor Cell Contaminated Leukapheresis Products With and Without Bortezomib With In-vivo Purging - Multiple Myeloma (MM)
- Status
- COMPLETED
- Phase
- PHASE2
Ixazomib (MLN9708) and Dexamethasone in High Risk Smoldering Multiple Myeloma: A Clinical and Correlative Pilot Study
- Status
- COMPLETED
- Phase
- PHASE1